Amrutanjan Health Care Limited — PPTs, 04-02-2026: Investor Presentation

Here's the concise, retail-friendly summary:

**1. Business Performance:**

Amrutanjan Health Care posted strong Q3 net sales of 141.04 Cr (+14.9%) and YTD sales of 352.78 Cr (+11.5%). Pain Management (Amrutanjan) and Women's Hygiene (Comfy) drove growth; Comfy's Q3 sales rose 22.6%, boosted by XL variants.

**2. Growth Drivers or Strategy:**

The company targets deeper market penetration and sales network expansion. This includes increased TV/digital media spending for awareness and rural van initiatives to expand reach.

**3. Recent Developments:**

AHCL launched Comfy Slimfit XXL Night Pads in Q3, broadening offerings. Distribution expanded with 40,000 new outlets.

**4. Key Financial Metrics:**

Q3 PBT was 26.36 Cr (+1.4%), PAT 19.45 Cr (+1.0%). YTD, PBT jumped 17.8% to 56.87 Cr, and PAT 17.0% to 41.73 Cr.

**5. Management Commentary / Outlook:**

Management credits strong execution for double-digit revenue/profit growth. Power brands (Amrutanjan, Comfy, Relief, Electro+) should drive health & wellness market share, with sustained double-digit growth projected for Q4.